Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets
- PMID: 2151572
- DOI: 10.1159/000216146
Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets
Abstract
To estimate the extent of the release of plasminogen activator inhibitor type 1 (PAI-1) from platelets following their accidental activation in vitro during blood collection, we studied the antigen levels of PAI-1 and beta-thromboglobulin (beta TG) in plasma and sera from 38 healthy volunteers. For each volunteer, we calculated the ratio of platelet-derived PAI-1/platelet-derived beta TG from the difference in their respective concentrations in serum and plasma. The mean +/- SD (0.012 +/- 0.003) and median (0.012) ratios were identical before and after 10 or 20 min of venous occlusion. The platelet contribution of PAI-1 in plasma was estimated by multiplying the plasma concentration of beta TG (as a marker of platelet activation) with the above-mentioned individual ratio. Under our conditions of blood collection (1/10 vol of 0.1 M citrate, pH 4.5, as anticoagulant, and handling of blood at 4 degrees C and within 30 min), the platelet contribution to the PAI-1 concentration in plasma was on average 12% and always negligible in plasma with high levels of PAI-1.
Similar articles
-
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.Blood. 1987 Nov;70(5):1645-53. Blood. 1987. PMID: 3117137
-
The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters.Thromb Haemost. 1989 Jun 30;61(3):511-6. Thromb Haemost. 1989. PMID: 2529663
-
Studies on the release of a plasminogen activator inhibitor by human platelets.Thromb Haemost. 1986 Apr 30;55(2):201-5. Thromb Haemost. 1986. PMID: 2940723
-
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.Thromb Haemost. 1990 Jun 28;63(3):361-6. Thromb Haemost. 1990. PMID: 2144918
-
Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma.Ric Clin Lab. 1990 Apr-Jun;20(2):113-7. doi: 10.1007/BF02877557. Ric Clin Lab. 1990. PMID: 2371491 Clinical Trial.
Cited by
-
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.J Thromb Thrombolysis. 1995;2(3):187-193. doi: 10.1007/BF01062709. J Thromb Thrombolysis. 1995. PMID: 10608023
-
Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial.J Clin Endocrinol Metab. 2015 Dec;100(12):4533-40. doi: 10.1210/jc.2015-3415. Epub 2015 Nov 18. J Clin Endocrinol Metab. 2015. PMID: 26580240 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous